Prognostic Markers of Acute Heart Failure With Chronic Kidney Disease
Recruiting
Observational Study
Chronic Kidney Diseases
Acute Heart Failure
Biomarker
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 20 – 90
- Sex
- Any
- Study type
- Observational
- Participants needed
- 155 (estimated)
- Sponsor
- Cheng-Hsin General Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Acute heart failure (AHF) is defined as new or worsening of symptoms and signs of heart failure and is the most frequent cause of unplanned hospital admission in elderly patients. N-terminal pro-brain natriuretic peptide (NT-pro-BNP) is one of the most developed prognostic markers for AHR patients and. NT-pro-BNP has limitations in terms of diagnostic or predictive accuracy in patients with chroni…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* hospitalized for acute heart failure
Exclusion Criteria:
* initial serum NT-proBNP level \<300ng/ml, pregnancy, amputated, and end-stage renal disease under regular dialysis
Contacts